Company / FCF Margin
Amphstar Pharmaceuticals, Inc. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
16.8%
FY2025
5-year range
13.1% / 23.5%
FY2021-FY2025
Trend
-28.5%
vs FY2024
Sector context
#38 of 134
Health Care
What the data says
At 16.8%, Amphstar Pharmaceuticals, Inc.'s fcf margin ranks #38 of 134 in the Health Care sector. FCF Margin has fluctuated over the past 10 years, ranging from -2.9% in FY2018 to 23.5% in FY2024.
Based on SEC 10-K filings.
16.8% in FY2025 with a 5-year CAGR of +10.1%.
Declined from 22.6% to 16.8% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +3.8pp
- 5-Year Change
- +10.1pp
- 10-Year Change
- -
Sector benchmark
#38 of 134 in Health CareTop 28% of 134This company 16.8% Sector average -637.8%
▼
+102.6% above sector average
Key checks
Key Insights
- In FY2025, fcf margin decreased 28.5% year-over-year.
- Currently 654.6pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2024.
- Lowest fcf margin in the period was in FY2018.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 16.8% | -28.5% |
| FY2024 | 23.5% | +4.4% |
| FY2023 | 22.6% | +72.7% |
| FY2022 | 13.1% | -18.9% |
| FY2021 | 16.1% | +140.8% |
| FY2020 | 6.7% | +11050.0% |
| FY2019 | 0.1% | +102.1% |
| FY2018 | -2.9% | -270.8% |
| FY2017 | 1.7% | -74.6% |
| FY2016 | 6.7% | +419.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026